MYCOF News and Press, Mydecine Innovations Group Inc

(TheNewswire) Vancouver, British Columbia, April 20, 2026 – TheNewswire – Noveris Health Sciences Inc. (the “ Company ”) (CSE: NVRS) (FSE: 0NF0) (OTC: MYCOF) announces that, as a result of a review by the British Columbia Securities Commission (the “ ...

(TheNewswire) Vancouver, British Columbia, March 26, 2026 – TheNewswire – Noveris Health Sciences Inc. (the “ Company ”) (CSE: NVRS) (FSE: 0NF0) (OTC: MYCOF) announces that the British Columbia Securities Commission (“ BCSC ”) issued an order ...

(TheNewswire) Vancouver, British Columbia – TheNewswire - March 18 , 2026 – Noveris Health Sciences Inc. (the “ Company ”) (CSE: NVRS) (FSE: 0NF0) (OTC: MYCOF) is pleased to announce that it has completed its previously announced non-brokered private placeme...

(TheNewswire) Vancouver, British Columbia, March 16 , 2026 – TheNewswire - At the request of CIRO, Noveris Health Sciences Inc. (the “ Company ”) (CSE: NVRS) (FSE: 0NF0) (OTC: MYCOF) wishes to confirm that the Company’s management is unaware of any materia...

(TheNewswire) VANCOUVER, BC – TheNewswire - March 13, 202 6 – Noveris Health Sciences Inc. ( CSE: NVRS ) ( FSE: 0NF0 ) ( OTC: MYCOF ) (the " Company ") is pleased to announce the launch of its new investor-facing website at http://noveris.health . The website h...

(TheNewswire)   Vancouver, British Columbia – TheNewswire - March 11 , 2026 – Noveris Health Sciences Inc. (the “ Company ”) (CSE: NVRS) (FSE: 0NF0) (OTC: MYCOF) is pleased to announce that it intends to complete a non-brokered private placement offerin...

2026-03-10 16:15:22 ET More on Mydecine Innovations Group Financial information for Mydecine Innovations Group Read the full article on Seeking Alpha For further details see: Noveris Health Sciences CEO Joshua Bartch resigns

(TheNewswire)   Vancouver, British Columbia, March 10, 2026 – TheNewswire — Noveris Health Sciences Inc. (the “ Company ”) (CSE: NVRS) (FSE: 0NF0) (OTC: MYCOF) announces today that Joshua Bartch has resigned as director, president and chief executive off...

(TheNewswire) Vancouver, British Columbia, March 6, 2026 — TheNewswire - Noveris Health Sciences Inc. (the “ Company ”) (CSE: NVRS) (FSE: 0NF0) (OTC: MYCOF) announces today the conversion of debentures in the aggregate principal amount of $8,188,628 (the “ D...

(TheNewswire) Vancouver, British Columbia, February 27, 2026 - TheNewswire — Noveris Health Sciences Inc. (the “ Company ”) (CSE: NVRS) (FSE: 0NF0) (OTC: MYCOF) announces today that JJK Holdings Ltd. (“ JJK ”) acquired a convertible debenture of th...